Table Of Content

VOLUME 27 1991 SUBJECT INDEX A9 cells, 213 Basal nuclear complex, 767 Circadian oscillation, 441 Acceptance, 379 Bed nucleus of the stria terminalis, 207, Circadian rhythm, 181, 333, 573, 839 Acetylcholine, 125, 641 255, 617, 651 Clonidine, 689 Acetylcholinesterase, 641, 767 Behavior, 403 Cocaine, 105, 721, 843 Acquisition, 287 Behavioral sensitization, 843 Cocaine, effects on brain development, 829 Actinonin, 545 Cocaine receptors, 853 Activation, 315 (?H]Cocaine, 853 Activity, 225 Colchicine, 19 Acute, 199 Conditioned taste aversion, 403 Acute phase response, 305 Connections, 651 A/D conversion, 145 Blood pressure, 47, 857 Convulsions, 75, 721 Adaptive behavior, 371 Body temperature (T,,,), 701, 857 Copulatory behavior, 713 Adenosine A, receptors, 101 Body weight, 341, 429, 505 Cordotomy, 1 Adenylate cyclase, 759 Body weight regulation, 359 Cortex, 641 Adinazolam, 689 Bovine retina, 669 Corticofugal projection, 141 Adipsia, 273 Brain B-spectrin, 187 Corticosteroid, 737 Adrenergic alpha/beta-receptor, 347 Brain development, 641 Corticosterone, 423 Afferent vagus, 511 Brain development, effects of cocaine, 829 Corticotropin-releasing factor, 321 Aging, 237, 587, 685 Brain lesions, 403 Corticotropin-releasing hormone, 517, 617 Aging and haloperidol, 279 Brain slice, 321, 747 Cortisol, 181 Albumin, 283 Brainstem, 59, 581 Cross-sensitization, 105 Aldosterone, 315 Brain stimulation reward, 791 CSF, 283 Alloxan, 35 Brown adipose tissue, 501 Culture, 747 Alpha-2 adrenoceptors, 353 Buspirone, 693 Current evoked potential, 53 Alpha2-antagonist, 231, 237 Cyclic patterns, 93 Alpha-fluoromethylhistidine (FMH), 371 CA,, 689 Cyclo (His-Pro), 129 Aluminum, 819 CA, region, 693 8-Cyclopentyl-1 ,3-dipropylxanthine, 101 Alzheimer’s disease, 115, 631 CA3, 219 -Cyclopenty! d ine, 101 Amastatin, 545 Cadmium, 5 Cytokine, 273, 701, 737 Aminergic synapses, 175 Calcitonin gene-related peptide, 41, 605, 617 Amino acid sequence, 157 Calcium, 5 D-1 receptors, 379 Amino acids, 429 Calcium-dependent potassium conductance, 5 D-2 receptors, 379 Aminopeptidase M, 545 Caloric regulation, 423 Data sampling, 145 Amphetamine, 791 cAMP, 839 Dehydration, 299, 495 Amphetamine metabolite, 81 Capillaries, 487 Dehydration natriuresis, 495 d-Amphetamine, 129 Carbachol, 59 Delta, 93 Amygdala, 85, 595, 625, 791 Carbohydrate, 333 Demasculinization, 713 Cardiac autonomic ganglion, 175 Dementia, 819 Catecholaminergic neuron, 441 Dentate gyrus, 13 Angiotensin, 315, 397, 469, 545 Cats, 553 2-Deoxy-D-glucose, 517 Angiotensin I, 97 Caudate, 463 2-Deoxyglucose, 353 Angiotensin II, 97 cDNA, 157, 187 DDe presstihoynl,i m8i3p9r amine, 601 Angiotensin III, 97 Cell membranes, 487 Animal hypnosis, 59 Central actions, 247 Developing visual cortex, 675 Anorexia, 273, 299, 309 Central nervous system, 819 Development, 261, 805 Anterior hypothalamic preoptic area Central nucleus, 85, 625, 651, 791 Developmental plasticity, 553 (AH/"OA), 273 Cerebellar grafting, 669 Dexamethasone, 737 Anterograde transport, 255 Cerebellum, 581 Dextrorphan, 721 Anticholinesterase, 231, 237 Cerebral asymmetry, 261 2DG, 409 Cerebral cortex, 115, 631 Dietary-induced obesity, 535 Cerebral ischemia, 759 Dietary selection, 423 Cerebral v: , 0S Direct projections, 85 Cerebrospinal fluid, 819 Diuresis, 739 Chemical senses, 63 DOPAC, 129 Atrial natriuretic peptide, 247, 739 Dopamine, 129, 213, 225, 267, 379, 707, Auditory cortex, 133, 141 725, 739, 743, 857 Auditory evoked potentials, 133 Dopamine uptake, 105 Automated data processing, 573 Choline acetyltransferase, 767 Dopaminergic neurons, 81, 163 Autonomic, 63 Cholinergic, 47, 125 Dorsal grey commissure, 41 Autonomic nervous system, 541 Cholinergic and noncholinergic neuron loss, Dorsal hippocampus, 697 Autoradiography, 611, 759 119 Dorsal raphe, 693 Cholinergic fiber, 59 Dorsal root ganglion, 41 Baclofen, 75 Cholinergic neurons, 767 Double labeling, 675 Bar pressing, 387 Cholinergic system, 587 Double-labeling i ytoch Barium, 5 Chronic, 199 Drinking, 97, 273, 469 Basal ganglia, 463 Duodenum, 435, 521 DuP 753, 97 GFAP, 169 Insulin, 429, 505, 535 Dynorphin, 849 Glutamate receptors, 721 Interaction, 137, 231, 237 Glucagon, 409 Interferon a, 309 E groups, 367 Glucocorticoid, 737 Interhemispheric transfer, 553 Eating, 273 Glucoprivic feeding, 353 Interleukin-1, 305, 737 EC cell, 521 Glucose, 429, 435 Interleukin-1B, 309 EEG, 93, 231, 573 Glucose responsive neurons, 309 Internigral connections, 213 Efferent activity, 393 Glucose-sensitive neuron, 451 Intestinal lipid absorption, 477 Efferent vagus, 511 Glucose transporter, 501 Intestinal lipid metabolism, 477 Electrical stimulation, 207, 451 Glucose uptake, 501 Intra- and extraneuron, 81 3M D-Glucose, 35 Intracellular recording, 321 Glycogen, 435 Intracerebroventricular (ICV), 75 Electron microscopy, 255 GMI ganglioside, | lon channels, 747 Electrophysiological differentiation, 53 GnRH, 241 Electrophysiology, 163, 327, 469, 693 Golden hamster, 353 EMG, 145 Greater splanchnic nerve, 797 Islet of Langerhans, 505 Endoplasmic reticulum, 487 Growth factor, 737, 805 Isolation of brain neurons, 747 Energy balance, 333 Growth hormone, 181 Energy intake, 417 Gustatory system, 383 Kainic acid, 521 Energy metabolism, 501 Gut, 429 Ketamine, 75 Enkephalin, 707, 805 GVG, 287 Kindling, 791, 815, 835 Enzyme immunoassay, 685 Gyrus dentatus, 291 Epilepsy, 815 Laboratory computer, 145 EPSP-spike coupling, 13 Haloperidol and cognitive functioning, 279 Lateral hypothalamic area, 451, 521 Erythrocytes, 283 Haloperidol-induced catalepsy, 279 Lateral hypothalamus, 327, 341, 347 Estrogen, 261 Hamster, 63 Lateral preoptic area, 359 Ethanol reinforcement, 267 Heart rate, 47, 541 Learning ability, 291 Evoked neuronal discharge, 115 Hedonics of taste, 379 Learning performance, 199 Evoked potentials, 447 Hippocampal dentate gyrus, 815 Lesion, 231 Extended amygdala, 651 Hippocampal formation, 457 Leukocytes, 283 Extinction, 809 Hippocampal theta rhythm, 637 LH, 241 Extracellular fluid, 5 Hippocampus, 13, 219, 291, 611, 689, 693, LH-lesions, 517 Extracellular recording, 321, 825 747, 759, 839, 853 Limbic, 207 Histamine H,- and H,-receptors, 371 Lipids, 435 Fast Blue, 625 Histaminergic system, 367 Lipolysis, 483, 487 Fasting, 387 Hormone-sensitive lipase, 487 Lipoprotein lipase, 487 Fat, 429 Hourglass (homeostatic) principle, 441 Liver, 429, 435, 529 Fat cells, 483 HRP, 85 Locomotion, 743 Fat intake, 379 5-HT, 521, 675 Locomotor activity, 105 Feedforward inhibition, 13 5-HT,, agonists, 693 Locus coeruleus, 5, 693 Feeding, 273, 333, 341, 359, 371, 435, 451, 5-HT immunoreactivity, 843 Long-term depression, 115 463, 737 Human, 541 Long-term potentiation, 13, 219, 291, 403 Feeding behavior, 457 Human brain, 631 Fenfluramine, 341, 517 Hunger, 273 M35, 631 Fetal cells, 707 HVA, 129 Macrophage inflammatory protein-1 (MIP-1), Fever, 309, 701 HVS, 237 273, 701 Fibroblast growth factors, 327 p-Hydroxyvamphetamine, 81 Male chimpanzees, 241 Fixed-interval, 225 6-Hydroxydopamine, 707 MAO-A, 81 Flunitrazepam, 611 Hyperglycemia, 353 MAO-B, 81 Fluorescent dyes, 651 Hyperinsulinemia, 511 (*H]Mazindol binding, 353 Fluorescent tracer, 141 Mecamylamine, 125, 137 a-Fl thylhistidine, 367 Medial prefrontal cortex, 225 Fodrin, 195 Melatonin, 181, 595 Food, 387 Memory, 101, 125, 403 Food deprivation, 341 Hypothalamic paraventricular nucleus, 299 Mesencephalic reticular formation, 595 Food intake, 327, 423, 429, 505, 529, 737 Hypothalamic slice preparation, 825 Mesolimbic dopamine, 791 Food intake and thirst, 495 Hypothalamic transection, 637 Mesolimbic dopaminergic system, 359 Food intake regulation, 29 . 255, 273, 333, 505, 595, Food reward, 379 701, 725, 839, 853 Footshock, 601 Free water clearance, 495 Ibo, 199 Frequency analysis, 93 Immune system, 737 Fructose, 435 Immunoglobulin G, 255 Functional recovery, | I histochemistry, 19, 255, 617, 631 In situ hybridization, 19, 805 GABA, 13, 75, 835 In vivo electrochemistry (voltammetry), 689, GABA, receptor, 731 693 Mitochondrial oxidation, 435 In vivo voltammetry, 689 MK-801, 41, 75, 721, 835 Gastric vagal branches, 797 Inbred mouse strains, 163 Molecular genetics, 187 GBR 12909, 105 Inferior colliculus, 141 Monkey, 451, 457, 463 Gene expression, 731, 805 Ingestion, 327 Monoacylglycerol lipase, 487 Gerbil, 759 Inositol triphosphate, 759 Monoamine oxidase (MAO), 81 Monoclonal antibody, 669 Oral ethanol self-administration, 267 Raphe nuclei, 675 Monosaccharides, 435 Organization, 315 Rapid kindling, 815 Morphine, 35, 611 Organum cavum pre-lamina terminalis, 469 Rat, 29, 35, 47, 109, 133, 141, 151, 157, Morphology, 53, 63 Organum vasculosum laminae terminalis 225, 251, 267, 283, 341, 387, 409, 435, Mossy fibers, 219 (OVLT), 495 521, 573, 617, 637, 737, 805, 809, 839, Motivation, 463 Ornithine decarboxylase, effects of cocaine, 843 Motor, 463 829 Rat brain, 19, 697 Motor activity, 207 Osmolal clearance, 495 Rat cerebellum, 669 Motor central pattern generator, | Osmolality, 469 is,2 9 Rat neuronal histamine, 371 Motor set, 751 oO +, i Receptor regulation, 731 Motor units, 145 Ototoxicity, 109 Recognition of food, 457 Mouse, 187, 601, 849 Oxotremorine-M, 115 Red blood cells (RBC), 663 Mouse brain, 731 Oxytocin, 299 mRNA, 157, 187, 707 aMSH, 309 PA, 587 Multiunit activity, 595 Pallidum, 463 Muscarinic, 125 Parabrachial nucleus, 797 Muscarinic acetylcholine receptor, 631, 697 Parasympathetics, 541 Muscarinic agonist, 115, 237 Paraventricular nucleus (PVN), 321, 333, Muscimol, 75 371, 447 Parkinson's disease, 707 NIE-115 clonal cell, 53 Partial reinforcement extinction effect, 809 Naloxone, 219, 241 Parvalbumin, 697 Natriuresis, 739 Passive avoidance, 101, 119, 287 Natural killer cells, 309 Patch-clamp experiment, 747 Ro 15-1788, 251 Nausea, 299 PD 117302, 75 NBM, 287 Pentylenetetrazol, 835 $100, 157 Need-free salt intake, 315 Peptide, 819, 825 Salt appetite, 315 Neonatal rat, | Perforant path, 13 Salty, 393 Nerve cell bodies, 19 Periaqueductal gray, 625 Sated rat, 347 Nerve growth factor, 685 Periodontal senosory endings, 29 Satiety, 299, 435, 495 Nervous system, 737 Peripheral benzodiazepines, 13 SCH 23390, 725 Neural transplantation, | Petit mal epilepsy, 849 Sciatic nerve, 47 Neuroanatomical tract tracing, 255 Phenobarbital, 109 SCN-independent oscillator, 441 Neurofilament, 169 Phosphorylation, 195, 731 Scopolamine, 125, 137 Neuroimmunology, 737 Physiological challenges, 359 Second messenger, 759 Neuron activity, 463 Picrotoxin, 13 Seizure activity, 815 Neuronal insult, 815 Pigeon, 581 Seizures, 13 Neuropeptide Y (NPY), 517, 663 Pilocarpine, 35, 125 Selective attention, 751 Neuropeptides, 605 Plasma osmolality, 495 Self-stimulation, 225, 341, 601 Neuroplasticity, 815 Platelet-derived growth factors, 327 Sensitization, 105, 791 Neurotensin, 617 Piatelet-rich plasma (PRP), 663 Neurotoxicity, 843 Polycose, 383 Nicotine, 125 Polysaccharides, 383 Septohi . Nicotinic, 125 Population spike, 13 Serotonin (5-HT), 663, 689, 693, 843 NMDA, 75, 291 Posterior hypothalamus, 637 Sex difference, 685 NMDA receptor, 403, 835 Postnatal development, 767 Sexual differentiation, 713 Nodose ganglion, 151 Sexually dimorphic brain areas, 261 Nonpeptide angiotensin I] antagonist, 97 Sexually dimorphic nucleus, 713 Noradrenalin (NA), 663 SI cortex, 751 Norepinephrine, 347, 689, 693 Prenatal protein malnutrition, 809, 815 SIF cells, 175 Norepinephrine turnover, 305 Preoptic area, 701, 713 Sigma, 93 Nucleus accumbens, 225, 267, 743 Preproenkephalin, 805 Single-cell recording, 553 Nucleus basalis, 137, 199, 231 Preproenkephalin A, 19 Single unit recording, 457 Nucleus basalis magnocellularis, 119 Primary afferents, 41 Skeletal muscle, 501 Nucleus of the solitary tract, 447 Prolactin, 181 Sleep, 93, 251, 573 Nucleus tractus solitarius, 797 Propranolol-sensitive binding, 483 Sleep architecture, 573 Nutrient selection, 409 Proprioceptive afferents, 1 Sleep spindles, 93 Nutrients, 429 Protein kinase C, 707, 731, 759 Sodium appetite, 397 Nutrition, 541 Protein nutrition, 417 Spectrin, 195 Puberty, 241 Spinal cord, 47, 151, 581 Obesity, 333 Purkinje cells, 669 Spinal cord injury, 1 Odor preferences, 387 PVN-lesions, 517 Spinocerebellar pathways, 581 6-OHDA injection, 359 Spiperone, 725 Olfaction, 387, 451 Quiet biting attack, 725 Spleen, 305 Olfactory bulb, 447 Quinpirole, 163, 743 Split brain, 553 Olfactory bulbectomy, 839 Quis, 199 Spontaneously hypertensive rat, 247, 545, Olfactory tubercle, 853 853, 857 Ontogeny of ingestion, 379 Rabbit, 435, 625 Sprouting, 41 Opioid, 241, 805 Radial-arm maze, 125 Stereospecificity, 75 «-Opioid agonists, 75 Radial arm maze performance and Steroids, 333, 737 Opioid receptors, 219 haloperidol, 279 Stimulation-induced feeding, 347 Stress, 207, 225 Urine concentration, 495 Striatum, 141, 707, 747, 767, 853 Urine osmolality, 495 Subarachnoid hemorrhage (SAH), 605, 663 Substantia nigra, 19, 213, 463 Vagus nerve, 393 Sucrose, 383, 535 Thermoregulation, 273, 371, 701 Vasopressin, 247, 299, 495 Sulcal prefrontal cortex, 225 Thermosensitive neurons, 309 Vasospasm, 663 Superior salivatory nucleus, 85 Thirst, 495 Ventral tegmental area, 463 Suprachiasmatic nucleus, 409, 839 Tissue distribution, 157 Ventromedial hypothalamus (VMH), 273, Sweet, 393 Toluene, 109 371, 501 Sympathetic nerve, 501 Toluene metabolism, 109 VHM neurone activity, 29 Sympathetic nervous system, 305 Tottering, 849 Visual cortex, 553 Synapsin I, 195 Toxins, 299 VMH-lesions, 517 Synaptic plasticity, 291 Transplantation, 707 VMH obesity, 511 Synaptic transmission, 195 Triacylglycerol, 487 Voluntary movement, 59 Synaptic vesicles, 195 Trigeminal nerve, 379 Synenkephalin, 19 Triglycerides, 535 Water balance, 273, 495 Water-maze, 119, 287 Tuberomammillary nucleus, 367 WGA-apoHRP-Gold, 675 Tachykinins, 315 Tago technique, 641 U-50488H, 75 WGA-HRP, 151, 625 Taste, 63, 535 U-53445E, 75 Wistar-Kyoto rats, 853 Taste-flavoring, 417 U-69593, 75 Yohimbine, 689 Taste preferences, 383 Ultrasonic vocalizations, 261 *°S-TBPS binding, 835 Umami, 393 Zucker obese rats, 371 AUTHOR INDEX Abbott, L. C., 849 Bray, G. A., 517 Feinberg, I., 93 Hashida, A., 409 Acevedo-Cruz, A., 435 Broderick, P. A., 689, 693 Fernandez-Lopez, A., 611 Hattori, S., 463 Adachi, A., 529 Bronzino, J. D., 815 Foreman, R. D., 151 Hattori, T., 141 Akiyoshi, M., 305 Buccafusco, J. J., 47 Foster, G. A., 809 Hiroshige, T., 441 Albers, H. E., 825 Budzikowski, A., 247 Fregly, M. J., 97 Hirsch, J., 541 Amir, H. Z., 545 Burt, D. R., 731 Fu, Q.-G., 151 Hisamitsu, T., 59 Andrew, M., 721 Butcher, L. L., 767 Fujimiya, M., 521 Ho, I. K., 279, 721, 853 Angel, A., 175 Fujimoto, K., 371, 477 Hoebel, B. G., 341 Angel, I., 353 Cadet, J. L., 707 Fujimoto, Y., 403 Holman, S. D., 261 Angulo, J. A., 707 Callahan, P. M., 843 Fujishita, M., 59 Honma, K., 441 Aou, S., 451 Calvo, P., 611 Fukagawa, K., 371 Honma, S., 441 Arai, Y., 81, 685 Caroli, M., 605 Fukuda, M., 457 Hori, T., 309, 451 Araki, T., 759 Carrer, H. F., 291 Fukui, Y., 85 Hoskins, B., 279, 853 Arienta C., 605 Casada, J. H., 207 Fumagalli, G., 605 Hutchison, J. B., 261 Arisawa, T., 669 Cassell, M. D., 651 Funahashi, M., 529 Arluison, M., 19 Castellano, M. A., 213 Ichiyama, M., 85 Armstrong, D. L., 447 Castonguay, T. W., 423 Galbraith, J. M., 41 lizuka, R., 685 Asano, T., 663 Chandler, M. J., 151 Galler, J. R., 809 Ikegaki, I., 663 Aste, N., 713 Chen, M., 553 Garcia-Diaz, D. E., 447 Inagaki, N., 367 Aston-Jones, G., 5 Chiang, C., 5 Geic, M., 835 Inenaga, K., 321 Austin-Lafrance, R. J., 815 Cierco, M., 739 Geiselman, P. J., 435 Inoue, S., 511 Azari, R., 93 Cobbett, P., 53 Gelerstein, S., 553 Isayama, T., 805 Commissiong, J. W., | German, D. C., 163 Israel, A., 739 Balbi, S., 605 Corda, M. G., 835 Giacobini, E., 631 ltowi, N., 367 Baldo, B. A., 105 Cosgrove, C., 53 Balkan, B., 505 Csonka, K., | Jakala, P., 237, 287 Balthazart, J., 713 Cunningham, K. A., 843 Jandé, G., 359 Banks, W. A., 819 Jin, C., 853 Bansinath, M., 75 Dafny, N., 207 Johansson, B. B., 283 Barbella, Y.. 739 Dahl, D., 169 Ju, G., 617 Barber, W. D., 797 Dai, K.-S., 13 Barnes, A. M., 279 Date, I., 669 Kaizuka, Y., 309 Barraco, R. A., 101 Davis, B. J., 63 Kalivas, P. W., 267 Barrera, C. M., 819 de Jong, G. I., 697 Kani, K., 675 Bernardini, G. L., 163 Derrick, B. E., 219 Kapp, B. S., 625 Bignami, A., 169 Douglas, V. D., 751 Kari, Z., 359, 451 Bianchette-Mackie, E. J., 487 Blank, M. S., 241 Egawa, M., 511 Block, W. D., 535 El Ghissassi, M., 469 Bodnar, R. J., 35 Epstein, A. N., 315 Borowski, T. B., 791 Eto, K., 685 Bourgoin, S., 19 Boyer, P.-A., 19 Farley, J. M., 721 Katoh-Semba, R., 685 Murphy, J. R., 241 Riekkinen, M., 119, 199, Takashima, Y., 387 Kawada, T., 417 Murray, C. E., 545 231, 237, 287, 587 Take, S., 309 Kawasaki, M., 387 Muto, T., 327 Riekkinen, P., 119, 137, 199, Takeshige, C., 59 Kelley, A. E., 105 Myers, R. D., 273, 701 231, 237, 287, 587 Takeuchi, Y., 85 Kest, B., 35 Riekkinen, P., Jr., 119, 137, Tamura, R., 457 Kim, S. K., 81 Nagai, K., 409 199, 231, 237, 287, 587 Tanaka, K., 511 Kimura, H., 327, 521 Nagase, H., 511 Roberts, K. A., 545 Taranger, M.-A., 353 Kinemuchi, H., 81 Nakagawa, H., 409 Roberts, L., 651 Tatebayashi, H., 747 Kisara, K., 81 Nakashima, T., 309 Rockhold, R. W., 721, 853 Tejwani, G. A., 849 Kjellman, B. F., 181 Nakazawa, M., 675 Rodriguez Diaz, M., 213 Klein, C. M., 41 Naranjo-Rodriguez, E. B., Roncagliolo, M., 573 Koegler, S. M., 829 595 Rose, J. E., 125 Kogure, K., 759 Narasimhan, V. N., 839 Rowland, N. E., 97 Koh, T., 675 Necker, R., 581 Koivisto, E., 137 Nelson, R. J., 751 Saito, A., 663 Tolliver, G. A., 267 Kokkinidis, L., 791 Nicolaidis, S., 469 Saito, M., 305, 511 Tonkiss, J., 809 Koopmans, H. S., 429 Niijima, A., 393 Sakata, T., 371 Tooyama, I., 327 Kriebel, R. M., 175 Nishijo, H., 457 Samson, H. H., 267 Torii, K., 417 Kuiper, H., 109 Nishikawa, K., 409 Sancibrian, M., 701 Torres, M., 739 Kutscher, C. L., 641 Nishimura, Y., 85 Sandor, P., 359 Trub, M., 29 Nishino, H., 451, 463 Sasaki, K., 327 Tso, P., 477 Lahtinen, H., 587 Nishizuka, M., 685 Satoh, N., 81 Tsujita, T., 483 Lammintausta, R., 231, 237 Norgren, R., 397 Satoh, S., 511, 663 Turndorf, H., 75 Laouris, Y., 145 Normile, H. J., 101 Sauve, Y., 1 Lawson, K., 279 Novin, D., 435 Scheurink, A. J. W., 505 Uchida, S., 93 Lee, J. M., 843 Schréder, H., 631 Urbancic, M., 251 Leibel, R. L., 541 O'Connor, S. D., 251 Sclafani, A., 383 Uwano, T., 387 Leibowitz, S. F., 333 Oden, G., 721 Scow, R. O., 487 Lénard, L., 359 O'Farrell, L., 435 Seidler, F. J., 829 Vagell, M. E., 839 Levin, E. D., 125 Shaikh, M. B., 725 Valjakka, A., 231, 287, 587 Levy, A., 129 Shaw, N. A.. 133 van der Zee, E. A., 631, 697 Li, B., 751 Sherburn, E. W., 41 Vankova, M., 19 Lin, Y., 115 Shew, R. L., 41 Vaughn, L. K., 857 Liou, S. Y., 825 Ono, T., 387, 457, 463 Shibuya, M., 663 Verbalis, J. G., 299 Lon, S., 247 Ookuma, K., 371 Shiekhattar, R., 5 Viglietti-Panzica, C., 713 Lu, C.-L., 725 Oomura, Y., 327, 359, 451 Shimazu, T., 501 Vivaldi, E. A., 573 Lubin, E., 35 Ootani, K., 409 Shimizu, Y., 305 Luiten, P. G. M., 631, 697 Orlandi, M., 835 Shiraishi, T., 347 Wada, H., 367 Lumia, A. R., 839 Oyama, K., 81 Shukla, V. K., 75 Walls, E. K., 429 Siegel, A., 725 Wang, J. B., 731 McClelland, R. C., 341 Panzica, G. C., 713 Sikorski, A. F., 195 Ward, P. E., 545 McGinnis, M. Y., 839 Sirvié, J., 137, 199, 231, Wayner, M. J., 447 McGregor, I. S., 225 237, 287, 587 Weinberger, S. B., 219 McNeill, D. L., 41, 151 Slotkin, T. A., 829 Smith, G. P., 379 Solano-Flores, L. P., 447 Song, W., 157 Willing, A. E., 429 Soria, C., 611 Wilson, A., 625 Spencer, J. R., 829 Wolfe, C., 601 Phillis, J. W., Steffens, A. B., 505 Woolf, N. J., 767 Piercey, M. F., 693 Stepniakowski, K., 247 Woolley, D. E., 13 Pilcher, B. K., 41 Stillman, M. J., 129 Wright, J. W., 545 Plata-Salaman, C. R., 737 Stricker, E. M., 299 Wu, M., 743 Possidente, B. P., 839 Strosberg, A. D., 631, 697 Prakash, M. R., 397 Strubbe, J. H., 505 Yamamoto, T., 403 Prieto-Gémez, B., 595 Struble, R. G., 631 Yamashita, H., 321 Pryor, G., 109 Sudo, M., 501 Sugita, K., 663 Quignon, M., 19 Sun, N., 651 Mifiano, F. J., 273, 701 Quock, R. M., 857 Suzuki, K., 327 Yoshimatsu, H., 359, 371 Minokoshi, Y., 501 Suzuki, Y., 663 Yuan, C.-S., 797 Radulovacki, M., 251 Szczepanska-Sadowska, E.., Ramabadran, K., 75 247 Zacharko, R. M., 601 Ramirez, O. A., 291 Zagon, I. S., 805 Ramsay, D. J., 495 Tabuchi, E., 387 Zernicki, B., 637 Rattan, A. K., 849 Tadano, T., 81 Zhu, S.-M., 707 Rauch, T. M., 129 Takahashi, A., 501 Zilles, K., 631 Rebert, C., 109 Takahashi, H., 47 Zimmer, D. B., 157 Reinking, R. M., 145 Takaki, A., 451 Zimmer, W. E., 157, 187 Reyes-Vazquez, C., 595 Takamura, Y., 511